Karyopharm Therapeutics Inc.
KPTIQ· OTC
Released Nov 9, 2015, before the open
10-Q filed Nov 9, 2015, 40 days after period end · 0001193125-15-370974
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2015 | Q3 2014 | Q3 2013 | Q3 2012 |
|---|---|---|---|---|
| Revenue | $75.00K | $21.00K | $0.00 | $34.00K |
| Net Income | -$30.37M | -$19.72M | — | — |
| EPS Diluted | -$0.85 |
Karyopharm Therapeutics Inc. · CIK 1503802 · Engraved from SEC EDGAR
| -$0.61 |
| -$3.66 |
| -$1.97 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.